|Funding from Vinnova||SEK 300 000|
|Project duration||April 2012 - October 2012|
Purpose and goal
Apiconisis, a spin-off company from KTH and KI, is a life science company that offers advanced fluorescence-based services to develop 21st century pharmacology. Although we are a young company, the underlying technology and medical mechanism concept were to a large extent initiated by researchers at the Karolinska already in the 70 - and 80 s. So there is a long tradition and expertise in the Stockholm area in our field. Apiconisis is a product of this tradition.